WellDoc
Baltimore, US · Founded 2005 · Delaware corporation · 408 employees on LinkedIn · 8 known investors
Find your way into WellDoc
516 people in our graph share verified history with the WellDoc team — schools, employers, funds. One of them is your warm intro.
Javier Solterounlockedknows Anand Iyer · together at Carnegie Mellon University (overlapped)
×5knows the team · via James Madison University
knows the team · via Carnegie Mellon University
×2knows the team · via HLTH Inc.
knows the team · via University of Iowa
×2knows the team · via Carnegie Mellon University - Tepper School of Business
Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions. The company serves healthcare providers, health plans, and patients seeking evidence-based, technology-enabled chronic care management.
Founders & leadership
WellDoc was founded in 2005 by Ryan Sysko and Suzanne Clough.
RS
Ryan SyskoinFounder & Strategic Advisor2015–2016
SC
Suzanne CloughinChief Medical Officer and Co-Founder2005–2016Suzanne Clough is Executive Officer at WellDoc, an AI-driven digital health platform for cardiometabolic disease management. She has experience across the healthcare ecosystem including hospitals, clinics, disease management organizations, and pharmaceutical companies.
KM
Kevin McRaithinPresident and CEOKevin McRaith is President and CEO of WellDoc, an AI-driven digital health platform for cardiometabolic disease management. He brings more than 25 years of healthcare industry experience in leadership roles at biotech, pharmaceutical, and digital health organizations including Human Genome Sciences, Genentech, and Abbott.
AI
Anand IyerinChief AI OfficerChief AI Officer at WellDoc, Anand Iyer has led development of digital therapeutics for cardiometabolic disease management, including work on FDA-cleared digital therapeutic tools. He brings expertise in healthcare technology, AI strategy, and chronic disease management.
CB
Chris BergstrominChief Strategy & Commercial Officer2010–2015Chris Bergstrom is an executive officer at WellDoc, an AI-driven digital health platform for cardiometabolic disease management. He brings experience across sales, marketing, strategy, and business development roles in consumer products, pharmaceuticals, medical devices, and digital health sectors, including work with Fortune 500 healthcare companies, venture-backed startups, and management consulting.
Board
TL
Terry LiermanBoard director
MI
Michael I. GreenebaumBoard director
MK
Maxwell KahnBoard director
DL
David LevyBoard director
DV
Donald V. AlmeidaBoard director
Investors · 8
Merck Global Health Innovation Fund✓ verifiedRahway
Samsung Ventures✓ verifiedSeoul
Asset Management CompanyMenlo Park · $500K – $2M
DigiTx Partners LLCSan Francisco · $2M – $5M
Excel Venture ManagementBoston · $1M – $5Mvia Juan Enriquez · board
TCP Venture CapitalBaltimore
Windham Capital PartnersNew York · $1M – $5M
Johnson & Johnson Innovation – JJDCreportedNew Brunswick
Reported raises · per SEC filings
Form D private placements$49.6M disclosed across 4 rounds · 2013–2015
▶$29.1MraisedApr 2016 · 58 investors · Other Health CareRule 506(b)
▶$29.1MraisedApr 2016 · 58 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brandon GretzExecutive Officer
- Caroline YorkExecutive Officer
- Jen BeachellExecutive Officer
- Juan EnriquezDirector
- Donald V. AlmeidaDirector
- David I. StevensonDirector
- Kevin McRaithExecutive Officer, Director
- David LevyDirector
- Hyuk-Jeen SuhDirector
- Offering amount
- $31.6M
- Amount sold
- $29.1M
- Sales commissions
- $1.3M
- Proceeds to insiders
- $1.1M
- Placement agents
- Cowen and Company
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$225KraisedJul 2015 · 3 investors · Other Health CareRule 506(b)
▶$225KraisedJul 2015 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael I. GreenebaumDirector
- David LevyDirector
- Donald V. AlmeidaDirector
- Suzanne CloughExecutive Officer
- Terry LiermanDirector
- Anand IyerExecutive Officer
- Gene Van SlykeExecutive Officer
- Jen BeachellExecutive Officer
- David StevensonDirector
- Kevin McRaithExecutive Officer, Director
- Caroline YorkExecutive Officer
- Offering amount
- $1.5M
- Amount sold
- $225K
- Minimum investment
- $25K
- Proceeds to insiders
- $172.5K
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.5MraisedMar 2015 · 30 investors · Other Health CareRule 506(b)
▶$4.5MraisedMar 2015 · 30 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David LevyDirector
- Ryan SyskoExecutive Officer, Director
- Terry LiermanDirector
- Suzanne CloughExecutive Officer
- Kevin McRaithExecutive Officer
- Donald V. AlmeidaDirector
- Michael I. GreenebaumDirector
- Maxwell KahnDirector
- Offering amount
- $6M
- Amount sold
- $4.5M
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.7MraisedJan 2014 · 13 investors · Other Health CareRule 506(b)
▶$15.7MraisedJan 2014 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Maxwell KahnDirector
- Michael I. GreenebaumDirector
- David LevyDirector
- Donald V. AlmeidaDirector
- Suzanne CloughExecutive Officer
- Chris BergstromExecutive Officer
- Terry LiermanDirector
- Anand K. IyerExecutive Officer
- Ryan SyskoExecutive Officer, Director
- Offering amount
- $20M
- Amount sold
- $15.7M
- First sale
- Nov 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Nutrisense44 shared keywordsNutrisense provides personalized metabolic monitoring and health guidance through continuous glucose monitoring and data analysis. The platform helps individuals understand their body's metabolic response to food and lifestyle choices to build sustainable health habits.
Found38 shared keywordsFound offers clinically-led, personalized weight care that combines evidence-based medical treatment (including provider-prescribed medications) with support to help members lose weight and improve their health. It serves individuals seeking accessible, judgment-free weight management.
Companies competing with WellDoc for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does WellDoc do?
- Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions. The company serves healthcare providers, health plans, and patients seeking evidence-based, technology-enabled chronic care management.
- Who founded WellDoc?
- WellDoc was founded by Ryan Sysko, Suzanne Clough in 2005.
- Who are WellDoc's investors?
- WellDoc's investors include Merck Global Health Innovation Fund, Samsung Ventures, Asset Management Company, DigiTx Partners LLC, Excel Venture Management, TCP Venture Capital, Windham Capital Partners, Johnson & Johnson Innovation – JJDC.
- How much funding has WellDoc raised?
- WellDoc has disclosed $49.6M raised across 4 rounds.
- Where is WellDoc headquartered?
- WellDoc is headquartered in Baltimore, US.